Warrant exercise lifts IRSA (NYSE: IRS) shares outstanding to 846.1M

Rhea-AI Filing Summary

IRSA Inversiones y Representaciones S.A. reports that certain warrant holders exercised their rights between May 11 and 12, 2026. This exercise will result in the issuance and registration of 35,318,802 ordinary shares, each with a face value of ARS 10, and brought in USD 459,146 to the company.

Following these exercises, IRSA’s ordinary shares outstanding increased from 810,797,120 to 846,115,922. A remaining 149,100 warrants were not exercised and expired on May 12, 2026, closing out this warrant program.

Insights

Equity & Capital Structure Analyst

IRSA adds equity via warrant exercise with modest dilution.

IRSA received USD 459,146 in cash from warrant exercises that generated 35,318,802 new ordinary shares at a face value of ARS 10. This increased total outstanding shares from 810,797,120 to 846,115,922.

The transaction slightly dilutes existing shareholders while modestly increasing equity capital. All remaining 149,100 unexercised warrants expired on May 12, 2026, removing this derivative overhang from the capital structure going forward.

Key Figures

New shares issued: 35,318,802 shares Cash proceeds from warrants: USD 459,146 Shares outstanding before exercise: 810,797,120 shares +4 more

7 metrics

New shares issued 35,318,802 shares Ordinary shares from May 11–12, 2026 warrant exercise

Cash proceeds from warrants USD 459,146 Collected by company from May 2026 warrant exercises

Shares outstanding before exercise 810,797,120 shares Ordinary shares prior to May 2026 warrant exercise

Shares outstanding after exercise 846,115,922 shares Ordinary shares after May 2026 warrant exercise

Warrants exercised 26,243,776 warrants Warrants exercised in May 2026

Unexercised warrants expired 149,100 warrants Warrants that expired on May 12, 2026

Face value per share ARS 10 per share Face value of IRSA ordinary shares

Key Terms

warrants, ordinary shares, face value, Form 6-K, +2 more

6 terms

warrants financial

"certain warrants holders have exercised their right to acquire additional shares"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

ordinary shares financial

"a total of 35,318,802 ordinary shares of the Company will be registered"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

face value financial

"ordinary shares of the Company will be registered, with a face value of ARS 10"

Face value is the printed, original value of a financial instrument—what is written on a bond or share certificate as the amount it represents, like the price shown on a ticket. For investors it matters because face value determines the principal amount repaid at maturity and the basis for interest or coupon payments on bonds, and it affects legal and accounting measures for shares even if market price moves above or below that printed number.

Form 6-K regulatory

"IRSA INVERSIONES Y REPRESENTACIONES SOCIEDAD ANONIMA (THE “COMPANY”) REPORT ON FORM 6-K"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

Bolsa de Comercio de Buenos Aires regulatory

"letter dated May 19, 2026, filed by the Company with the Bolsa de Comercio de Buenos Aires"

Comisión Nacional de Valores regulatory

"filed by the Company with the Bolsa de Comercio de Buenos Aires and the Comisión Nacional de Valores"

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 FORM 6-K

 REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15b-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of May, 2026

 IRSA Inversiones y Representaciones Sociedad Anonima

(Exact name of Registrant as specified in its charter)

IRSA Investments and Representations Inc.

(Translation of registrant´s name into English)

 Republic of Argentina

(Jurisdiction of incorporation or organization)

Carlos Della Paolera 261 9th Floor

(C1001ADA)

Buenos Aires, Argentina

 (Address of principal executive offices)

 Form 20-F ⌧ Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No x

IRSA INVERSIONES Y REPRESENTACIONES SOCIEDAD ANONIMA

(THE “COMPANY”)

REPORT ON FORM 6-K

Attached is an English translation of the letter dated May 19, 2026, filed by the Company with the Bolsa de Comercio de Buenos Aires and the Comisión Nacional de Valores.

Buenos Aires, May 19, 2026 – IRSA Inversiones y Representaciones S.A. (NYSE:IRS;BYMA:IRSA), informs that between May 11 and 12, 2026, certain warrants holders have exercised their right to acquire additional shares.

Therefore, a total of 35,318,802 ordinary shares of the Company will be registered, with a face value of ARS 10. As a result of the exercise, USD 459,146 were collected by the Company.

After the exercise of these warrants, the number of shares of the Company increased from 810,797,120 to 846,115,922 with a face value of ARS 10, leaving a balance of unexercised warrants of 149,100, which expired on May 12, 2026.

The following table provides a summary of the information regarding the options and shares issued by the Company:

Ordinary shares prior to May-2026 exercise	810,797,120
Warrants exercised in May-2026	26,243,776
Shares issued for May-2026 exercise*	35,318,802
Outstanding ordinary shares after May-2026 exercise	846,115,922

*The amount includes rounding adjustments for each exercise instruction calculation.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Buenos Aires, Argentina.

	IRSA Inversiones y Representaciones Sociedad Anónima
	By:	/s/ Saúl Zang
		Saúl Zang
		Responsible for the Relationship with the Markets
May 19, 2026


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

FAQ

What did IRSA (IRS) announce in its May 2026 Form 6-K?

IRSA reported that certain warrant holders exercised their rights in May 2026. This resulted in issuing 35,318,802 new ordinary shares and collecting USD 459,146 in cash proceeds, with all remaining unexercised warrants expiring on May 12, 2026.

How many new IRSA (IRS) shares were issued from the May 2026 warrant exercise?

IRSA will register 35,318,802 new ordinary shares from the May 2026 warrant exercise. These shares have a face value of ARS 10 each and arise from warrants exercised between May 11 and 12, 2026 by certain holders.

How did the May 2026 warrant exercise change IRSA (IRS) shares outstanding?

IRSA’s ordinary shares outstanding rose from 810,797,120 to 846,115,922 after the May 2026 warrant exercise. This reflects the issuance of 35,318,802 new shares, modestly diluting existing holdings while increasing the company’s equity capital base.

How much cash did IRSA (IRS) receive from the May 2026 warrant exercise?

The company collected USD 459,146 from warrants exercised in May 2026. This cash inflow corresponds to the issuance of 35,318,802 new ordinary shares and adds to IRSA’s financial resources without incurring new debt obligations.

What happened to IRSA (IRS) warrants that were not exercised by May 12, 2026?

A remaining 149,100 IRSA warrants were not exercised and expired on May 12, 2026. Their expiration means these instruments can no longer be converted into shares, removing a small derivative component from the company’s capital structure.